Search Results - "Krefting, Ira"

Nephrogenic Systemic Fibrosis and Class Labeling of Gadolinium-based Contrast Agents by the Food and Drug Administration by LUCIE YANG, KREFTING, Ira, GOROVETS, Alex, MARZELLA, Louis, KAISER, James, BOUCHER, Robert, RIEVES, Dwaine

“…In 2007, the Food and Drug Administration requested that manufacturers of all approved gadolinium-based contrast agents (GBCAs), drugs widely used in magnetic…”
Get full text

First-Trimester Exposure to Gadolinium-based Contrast Agents: A Utilization Study of 4.6 Million U.S. Pregnancies by Bird, Steven T, Gelperin, Kate, Sahin, Leyla, Bleich, Karen B, Fazio-Eynullayeva, Elnara, Woods, Corinne, Radden, Erica, Greene, Patty, McCloskey, Carolyn, Johnson, Tamara, Shinde, Mayura, Krefting, Ira

“…BackgroundThe safety of gadolinium-based contrast agent (GBCA) exposure during pregnancy has not been established, and the use of GBCAs during pregnancy is not…”
Get full text

Risk of fetal or neonatal death or neonatal intensive care unit admission associated with gadolinium magnetic resonance imaging exposure during pregnancy by Winterstein, Almut G., Thai, Thuy N., Nduaguba, Sabina, Smolinski, Nicole E., Wang, Xi, Sahin, Leyla, Krefting, Ira, Gelperin, Kate, Bird, Steven T., Rasmussen, Sonja A.

“…Concerns have been raised about prenatal exposure to magnetic resonance imaging with gadolinium-based contrast agents because of nonclinical findings of…”
Get full text

Optimization of Detection of Gadodiamide Brain Retention in Rats Using Quantitative T 2 Mapping and Intraperitoneal Administration by Liachenko, Serguei M, Sadovova, Natalya V, Tripp, Arnold, Ghorai, Suman, Patri, Anil K, Hanig, Joseph P, Cohen, Jonathan E, Krefting, Ira

“…Currently, the gadolinium retention in the brain after the use of contrast agents is studied by T -weighted magnetic resonance imaging (MRI) (T w) and T…”
Get full text

Optimization of Detection of Gadodiamide Brain Retention in Rats Using Quantitative T2 Mapping and Intraperitoneal Administration by Liachenko, Serguei M., Sadovova, Natalya V., Tripp, Arnold, Ghorai, Suman, Patri, Anil K., Hanig, Joseph P., Cohen, Jonathan E., Krefting, Ira

“…Background Currently, the gadolinium retention in the brain after the use of contrast agents is studied by T1‐weighted magnetic resonance imaging (MRI) (T1w)…”
Get full text

Emerging technologies and their impact on regulatory science by Anklam, Elke, Bahl, Martin Iain, Ball, Robert, Beger, Richard D, Cohen, Jonathan, Fitzpatrick, Suzanne, Girard, Philippe, Halamoda-Kenzaoui, Blanka, Hinton, Denise, Hirose, Akihiko, Hoeveler, Arnd, Honma, Masamitsu, Hugas, Marta, Ishida, Seichi, Kass, George EN, Kojima, Hajime, Krefting, Ira, Liachenko, Serguei, Liu, Yan, Masters, Shane, Marx, Uwe, McCarthy, Timothy, Mercer, Tim, Patri, Anil, Pelaez, Carmen, Pirmohamed, Munir, Platz, Stefan, Ribeiro, Alexandre JS, Rodricks, Joseph V, Rusyn, Ivan, Salek, Reza M, Schoonjans, Reinhilde, Silva, Primal, Svendsen, Clive N, Sumner, Susan, Sung, Kyung, Tagle, Danilo, Tong, Li, Tong, Weida, Eijnden-van-Raaij, Janny van den, Vary, Neil, Wang, Tao, Waterton, John, Wang, May, Wen, Hairuo, Wishart, David, Yuan, Yinyin, Slikker Jr, William

“…There is an evolution and increasing need for the utilization of emerging cellular, molecular and in silico technologies and novel approaches for safety…”
Get full text

FDA perspective on ultrasound contrast agents safety and development by Krefting, I.

“…Regulatory actions through 2007-2008 demonstrate FDA's response to multiple reports of sudden death and severe cardiopulmonary reactions temporally related to…”
Get full text

Application of simple theoretical methods to the solution of chemical problems. III. Hyperconjugation vs. 1-3 conjugation as the mechanism for electron spin delocalization to .beta. fluorines by Underwood, Graham R, Vogel, Veronica L, Krefting, Ira

Get full text